Home » Topics » BioWorld Science

BioWorld Science
RSS

Turn Therapeutics reports in vivo data for OV-02 for shingles of the eye

Oct. 19, 2018

Ultra-deep sequencing brings new cancer gene insights, and questions

Oct. 19, 2018

Enanta initiates phase IIa study of EDP-938 in RSV challenge model

Oct. 18, 2018

Phase II study of rozanolixizumab achieves proof of concept in myasthenia gravis

Oct. 18, 2018

Proteostasis updates status of doublet and triplet cystic fibrosis programs

Oct. 18, 2018

GenSight reports 72-week data from REVERSE phase III trial of GS-010 in LHON

Oct. 18, 2018

MeiraGTx and Janssen enter gene therapy research collaboration and evaluation agreement

Oct. 18, 2018

Eiger reports phase II data on pegylated interferon lambda in HDV infection

Oct. 18, 2018

Bristol-Myers Squibb discovers PD-1/PD-L1 interaction inhibitors

Oct. 18, 2018

New 5-HT2C receptor agonists described by AbbVie

Oct. 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...